Human medicines European public assessment report (EPAR): Xolair, omalizumab, Asthma;Urticaria, Date 20 november Human medicines European public assessment report (EPAR): Xolair, omalizumab, Asthma;Urticaria, Date Human medicines European public assessment report (EPAR): Xolair, omalizumab, Asthma;Urticaria, Date of authorisation: 25/10/2005, Revision: 47, Status: Authorised Lees verder » Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief.